Transgene Biotek
Transgene Biotek (TRABI) share price was ₹2.36 at the 28 Oct 2026 close; market capitalisation ₹17.89 Cr; sector Healthcare Services. The share price fell 43.5% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was ₹0.06 Cr, against ₹0.05 Cr a year earlier and net profit was −₹0.39 Cr, against −₹0.43 Cr a year earlier (compared with Jun 2025). Promoters held 23.64% of Transgene Biotek in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 36/100 (Poor) as of 28 Oct 2026.
Key Fundamentals
MicrocapHealthcare ServicesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM
Peer Comparison
Healthcare › Healthcare Services › Healthcare Service Provider
| ₹1,906.60 | 58.95 | 32,002 Cr | 12.76 | 0.26% | 20.06% | 25.67% | 2,996 Cr | 545 Cr | |
| ₹1,438.40 | 78.90 | 14,815 Cr | 15.48 | 0.14% | 18.07% | 19.22% | 879 Cr | 187 Cr | |
| ₹549.85 | 56.51 | 11,403 Cr | 7.59 | 0.91% | 12.54% | 15.73% | 1,733 Cr | 203 Cr | |
| ₹516.20 | 46.59 | 8,216 Cr | 16.03 | 2.84% | 27.79% | 33.84% | 894 Cr | 176 Cr | |
| ₹630.30 | 150.43 | 6,338 Cr | 5.68 | 0.00% | 6.88% | 13.46% | 1,079 Cr | 85 Cr | |
| ₹319.10 | 46.38 | 1,662 Cr | 6.79 | 0.16% | 12.90% | 14.70% | 329 Cr | 35 Cr | |
| ₹494.80 | 16.23 | 1,605 Cr | 1.64 | 0.40% | 10.35% | 10.64% | 862 Cr | 98 Cr | |
| Transgene Biotek (this company) | — | — | 18 Cr | 2.13 | 0.00% | -6.74% | -0.33% | 1 Cr | -2 Cr |
| Median 8 companies | ₹549.85 | 56.51 | 7,277 Cr | 7.19 | 0.21% | 12.72% | 15.22% | 887 Cr | 137 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 91/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 23.6%
- Company has a low return on equity of -9.77% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
Oscillators
Bearish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
change over 1 year Operating margin -100% · Jun 2026
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.1 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | 0.05 | 0.06 |
| Expenses | 0.22 | 0.17 | 0.16 | 0.32 | 0.46 | 0.13 | 0.17 | 0.62 | 0.18 | 0.13 | 0.1 | 0.33 | 0.12 |
| Operating Profit | -0.12 | -0.12 | -0.11 | -0.27 | -0.41 | -0.07 | -0.09 | -0.54 | -0.13 | -0.08 | -0.05 | -0.28 | -0.06 |
| OPM % | -120% | -240% | -220% | -540% | -820% | -116.67% | -112.5% | -675% | -260% | -160% | -100% | -560% | -100% |
| Other Income | 0.04 | 0.04 | 0.04 | 0.05 | 0.65 | 0.04 | 0.04 | 0.04 | 0 | 0 | 0 | 0.15 | 0 |
| Interest | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.19 | 0.25 | 0.26 | 0.27 | 0.28 | 0.29 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 |
| PBT | -0.13 | -0.13 | -0.12 | -0.27 | 0.2 | -0.07 | -0.09 | -0.71 | -0.43 | -0.39 | -0.37 | -0.46 | -0.39 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -0.13 | -0.13 | -0.12 | -0.27 | 0.2 | -0.07 | -0.09 | -0.71 | -0.43 | -0.39 | -0.37 | -0.46 | -0.39 |
| EPS (₹) | -0.02 | -0.02 | -0.02 | -0.04 | 0.03 | -0.01 | -0.01 | -0.09 | -0.06 | -0.05 | -0.05 | -0.06 | -0.05 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.3 | 0.18 | 0.28 | 0.12 | 0.07 | 0 | 0.17 | 0.09 | 0.06 | 0.23 | 0.26 | 0.21 | 0.21 |
| Expenses | 1.9 | 1.32 | 2.84 | 2.22 | 0.75 | 0.87 | 0.7 | 0.55 | 0.68 | 0.83 | 1.38 | 0.75 | 0.68 |
| Operating Profit | -1.6 | -1.14 | -2.56 | -2.1 | -0.68 | -0.87 | -0.53 | -0.46 | -0.62 | -0.6 | -1.12 | -0.54 | -0.47 |
| OPM % | -533.33% | -633.33% | -914.29% | -1750% | -971.43% | — | -311.76% | -511.11% | -1033.33% | -260.87% | -430.77% | -257.14% | -223.81% |
| Other Income | 0.01 | 0.17 | 0.66 | 7.37 | 2.04 | 0.18 | 0.27 | 0.21 | 0.18 | 0.18 | 0.78 | 0.15 | 0.15 |
| Interest | 0.36 | 0.07 | 0.43 | 1.03 | 0.26 | 0.38 | 0.27 | 0.23 | 0.62 | 0.14 | 0.24 | 1.06 | 1.1 |
| Depreciation | 17.18 | 20.5 | 17.53 | 9.89 | 9.89 | 9.9 | 9.91 | 9.92 | 4.95 | 0.09 | 0.09 | 0.2 | 0.19 |
| PBT | -19.13 | -21.54 | -19.86 | -5.65 | -8.79 | -10.97 | -10.44 | -10.4 | -6.01 | -0.65 | -0.67 | -1.65 | -1.61 |
| Tax % | 0% | 0% | 0% | 13.98% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
| Net Profit | -19.14 | -21.54 | -19.86 | -6.44 | -8.79 | -10.96 | -10.43 | -10.4 | -6.01 | -0.66 | -0.68 | -1.65 | -1.61 |
| EPS (₹) | -2.53 | -2.84 | -2.62 | -0.85 | -1.16 | -1.45 | -1.38 | -1.37 | -0.79 | -0.09 | -0.09 | -0.22 | -0.21 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
| Reserves | 116 | 98.67 | -16.9 | -23.34 | -32.13 | -43.1 | -53.53 | -58.39 | -64.4 | -65.06 | -65.74 | -67.39 |
| Borrowings | 14.43 | 15.28 | 16.01 | 9.84 | 9.14 | 10.33 | 11.33 | 12.01 | 13.11 | 14 | 14.52 | 17.14 |
| Other Liabilities | 138 | 123 | 123 | 124 | 124 | 124 | 123 | 118 | 118 | 118 | 120 | 118 |
| Total Liabilities | 344 | 313 | 198 | 187 | 177 | 167 | 157 | 147 | 142 | 142 | 144 | 144 |
| Fixed Assets | 163 | 141 | 61.16 | 50.97 | 41.1 | 31.2 | 21.32 | 11.4 | 6.45 | 6.36 | 7.96 | 9.63 |
| CWIP | 0.29 | 0.29 | 2.04 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 1.87 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.09 |
| Other Assets | 180 | 172 | 135 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 | 134 |
| Total Assets | 344 | 313 | 198 | 187 | 177 | 167 | 157 | 147 | 142 | 142 | 144 | 144 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3.52 | 6.47 | 0.02 | -0.63 | -1.74 | 0.14 | 0.01 | 0.1 | 0 | 0 | 1.2 | -0.01 |
| Investing | -4.57 | -6.47 | 0 | 3.05 | 1.74 | 0 | -0.03 | -0.1 | -0.01 | 0 | -1.7 | 0.15 |
| Financing | 1.03 | 0 | 0 | -2.37 | 0 | -0.2 | 0 | 0 | 0 | 0 | 0.78 | -0.36 |
| Net Cash Flow | -0.02 | 0 | 0.02 | 0.05 | 0 | -0.06 | -0.01 | 0 | -0.01 | 0 | 0.28 | -0.22 |
| Free Cash Flow | -1.05 | 0 | 0.02 | 2.74 | -0.01 | 0.14 | -0.02 | 0.1 | 0 | 0 | -0.5 | 0.14 |
| CFO/OP | -220 | -568 | -1 | 30 | 256 | -16 | -2 | -22 | 0 | 0 | -107 | 2 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 19,953 | 3,326 | 13.04 | 30.42 | 52.14 | — | 21.47 | 40.56 | 60.83 | 15.87 | 14.04 | 17.38 |
| Inventory Days | — | — | — | 365 | 365 | — | 122 | — | 156 | — | — | — |
| Days Payable | — | — | — | 5,019 | 3,528 | — | 1,460 | — | 1,199 | — | — | — |
| Cash Conversion Cycle | 19,953 | 3,326 | 13.04 | -4,623 | -3,111 | — | -1,317 | 40.56 | -982 | 15.87 | 14.04 | 17.38 |
| Working Capital Days | -8,529 | -16,019 | -14,339 | -39,968 | -62,519 | — | -29,093 | -34,594 | -57,366 | -15,933 | -16,509 | -21,361 |
| ROCE % | -8.83% | -10.86% | -14.69% | -10.97% | -17.91% | -22.11% | -26.56% | -32.31% | -20.01% | -2.07% | -1.75% | -2.36% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Transgene Biotek insights
61 extracted metrics + investor summaries across FY09–FY27.
Documents
Frequently Asked Questions about Transgene Biotek
What does Transgene Biotek Ltd do?
Where is Transgene Biotek Ltd (TRABI) listed?
Which sector does Transgene Biotek Ltd belong to?
What is the market capitalisation of Transgene Biotek Ltd?
What is the 52-week high and low of Transgene Biotek Ltd?
What is the Return on Equity (ROE) of Transgene Biotek Ltd?
Company Information
Incorporated in 1990, Transgene Biotek Ltd is in the business of Research & Development[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/526139.md for Transgene Biotek Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.